Epidemiology of Neural Tube Defects and Their Distributions within a Cohort Study in Al-Diwaniyah Governorate
DOI:
https://doi.org/10.46966/msjar.v6i1.258Keywords:
Neural Tube Defects (NTDs); Spina bifida; AnencephalyAbstract
Background: Neural tube defect (NTD) may result from incomplete or complete failure of a neural tube to close during embryonic development. In areas where folic acid is not supplemented into the diet, the incidence of NTDs remains between 0.5 to 2 in every 1000 births. Objective is to assess the incidence of NTDs and plan comprehensive care pathways for children with open NTDs in Al Diwaniyah Iraq. Method: This diagnostic study spans of 22 years, with an encompassing all deliveries recorded at the maternity and child teaching hospital at Al Diwaniyah region in Iraq. Results: Of the 207 NTD patients evaluated, a birth prevalence rate of 9.4 per 1000 births was noted and a male to female ratio of approximately 3:1. The reports included spina bifida cases (66.6%), encephalocele cases (24.6%) and anencephalic cases (8.6%). 73.9 % or 153 of respondents who did not take folic acid during the first trimester. 134 (64.7%) mothers were discovered to belong to low income households, 20 (9.6%) very high income and 53 (25.6%) middle class. Of the 49 mothers in this study, only 38% were from urban regions while 62% were rural. 87% of the 163 cases had antenatal diagnosis conducted. Conclution: Folic acid supplementation is suitable for preventing the recurrence of neural tube defects (NTDs) in infants of high-risk women.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Wissam Saleh Hakim

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















